• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bicycle Therapeutics

News headline image
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
May 22, 2025
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
December 14, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Host R&D Day on December 14
November 30, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
October 19, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
September 11, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009
February 14, 2023
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Present Five Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) Programs at the SITC 37th Annual Meeting
November 10, 2022
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update
November 08, 2022
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
June 01, 2022
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Present Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
April 08, 2022
From Bicycle Therapeutics
Via Business Wire
Tickers BCYC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap